Muhammad Nasir

Muhammad Nasir


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2004 in BMB Reports
Verified
Journal Article
Open access
PDF file
MIMuhammad Ismail
Muhammad Ismail
NANaveed Akhtar
Naveed Akhtar
MNMuhammad Nasir
Muhammad Nasir
SFSadaf Firasat
Sadaf Firasat
QAQasim Ayub
Qasim Ayub
SKShagufta Khaliq
Shagufta Khaliq
Association between the Angiotensin-converting Enzyme Gene Insertion/Deletion Polymorphism and Essential Hypertension in Young Pakistani Patients ACE I/D polymorphism;Angiotensin-converting enzyme;Cross-sectional survey;Essential hypertension;Pakistani population; Several studies have demonstrated the importance of angiotensin-converting enzyme (ACE) insertion (I)/deletion (D) polymorphisms in the pathogenesis of hypertension. This study sought to determine the association between the ACE I/D polymorphism and essential hypertension in young Pakistanis. The frequency of the ACE I/D polymorphism was established by a comparative cross-sectional survey of Pakistani patients suffering from essential hypertension and ethnically matched normotensive controls. Samples were collected from tertiary care hospitals in northern Pakistan. Hypertensive individuals were defined as those with a systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg on three separate occasions, or those currently receiving one, or more, anti-hypertensive agents. DNA samples obtained from hypertensive (n=211) and normotensive (n=108) individuals were typed by PCR. The frequency of the ACE I/I genotype was significantly higher in hypertensive patients, aged 20-40 years, than in normotensive controls of the same age group ($\chi^2$ = 4.0, P = 0.041). Whereas no overall significant differences were observed between the I/I, I/D and D/D ACE genotypes (One way ANOVA, F=0.672; P=0.413). The association between the ACE I/I genotype and essential hypertension in individuals aged $\leq$ 40 years suggests that ACE has a role in early onset essential hypertension in Pakistan.

26 July 2011 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
MNMuhammad Nasir
Muhammad Nasir
ALAmir Latif
Amir Latif
MAMuhammad Ajmal
Muhammad Ajmal
RQReem Qamar
Reem Qamar
MNMuhammad Naeem
Muhammad Naeem
AHAbdul Hameed
Abdul Hameed
Lipoid proteinosis is a rare autosomal recessive disease characterized by cutaneous and mucosal lesions and hoarseness appearing in early childhood that is caused by homozygous or compound heterozygous mutations in theECM1gene located on chromosome 1q21. The aim of the study was to investigate the molecular genetic defect underlying lipoid proteinosis in a consanguineous Pakistani family.MethodsGenotyping of seven members of the family was performed by amplifying microsatellite markers, tightly linked to theECM1gene. To screen for mutations in theECM1gene, all of its exons and splice junctions were PCR amplified from genomic DNA and analyzed by SSCP and sequenced directly in an ABI 3130 genetic analyzer.ResultsThe results revealed linkage of the LP family to theECM1locus. Sequence analysis of the coding exons and splice junctions of theECM1gene revealed a novel homozygous mutation (c.616C > T) in exon 6, predicted to replace glutamine with stop codon (p.Q206X) at amino acid position 206.ConclusionsThe finding of a novel mutation in Pakistani family extends the body of evidence that supports the importance ofECM1gene for the development of lipoid proteinosis.

20 January 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
PDF file
AHA. Hameed
A. Hameed
MAM. Ajmal
M. Ajmal
MNMuhammad Nasir
Muhammad Nasir
MIM. Ismail
M. Ismail

13 December 2017 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
MAMuhammad Ajmal
Muhammad Ajmal
AMAsif Mir
Asif Mir
SWSughra Wahid
Sughra Wahid
CKChiea Chuen Khor
Chiea Chuen Khor
JFJia Nee Foo
Jia Nee Foo
MNMuhammad Nasir
Muhammad Nasir
Osteopetrosis is a rare inherited bone disorder mainly described as an increased bone density caused by defective osteoclastic bone resorption. To date, genetic variants of eleven genes have been reported so far to be associated with different types of osteopetrosis. However, malignant infantile osteopetrosis, a lethal form of the disease, is mostly (50%) caused by mutation(s) in TCIRG1 gene. In this study, we investigated a consanguineous Pakistani family clinically and genetically to elucidate underlying molecular basis of the infantile osteopetrosis. DNA samples from five family members were subjected to SNP-array based whole genome homozygosity mapping. Data was analyzed and potentially pathogenic mutation was identified by Sanger sequencing of two affected as well as three phenotypically healthy individuals in the family. The significance of identified pathogenic variation and its impact on protein structure and function was studied using various bioinformatics tools. DNA samples from five family members were subjected to genome-wide SNP array genotyping and homozygosity mapping which identified ~4 Mb region on chr11 harboring the TCIRG1 gene. Sanger sequencing unveiled a novel homozygous deletion c. 624delC in exon 6 of the TCIRG1 gene encodes a3 subunit of V-ATPase complex. The identified deletion resulted in a frame shift producing a truncated protein of 208 aa. In silico analysis of premature termination of the a3 subunit of V-ATPase complex revealed deleterious effects on the protein structure, predicting impaired or complete loss of V-ATPase function causing infantile osteopetrosis. Since a3 subunit of V-ATPase complex plays a crucial role in bone resorption process, structurally abnormal a3 subunit might have adversely affected bone resorption process, leading to infantile osteopetrosis in Pakistani family. Therefore, the present study not only expands the genotypic spectrum of osteopetrosis but also improve understandings of the role of V-ATPase a3 subunit in bone resorption process. Moreover, our findings should help in genetic counseling and provide further insight into the disease pathogenesis and potential targeted therapy.

5 July 2017 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
MAMuhammad Ajmal
Muhammad Ajmal
AMAsif Mir
Asif Mir
MSMuhammad Shoaib
Muhammad Shoaib
SMSalman Akbar Malik
Salman Akbar Malik
MNMuhammad Nasir
Muhammad Nasir
The dimerization efficiency of FGFR3 transmembrane domain plays a critical role in the formation of a normal skeleton through the negative regulation of bone development. Recently, gain-of-function mutations in the transmembrane domain of FGFR3 has been described associated with an aberrant negative regulation, leading to the development of achondroplasia-group disorders, including achondroplasia (ACH), hypochondroplasia (HCH) and thanatophoric dysplasia (TD). Here, we describe a non-consanguineous Pakistani family with achondroplasia to explain hereditary basis of the disease. PCR-based linkage analysis using microsatellite markers was employed to localize the disease gene. Gene specific intronic primers were used to amplify the genomic DNA from all affected as well as phenotypically healthy individuals. Amplified PCR products were then subjected to Sanger sequencing and RFLP analysis to identify a potentially pathogenic mutation. The impact of identified mutation on FGFR3 protein’s structure and stability was highlighted through different bioinformatics tools. Genetic screening of the family revealed a previously reported heterozygous c.1138 G > A (p.G380R) mutation in the coding exon 8 of FGFR3 gene. Identified genetic variation was confirmed in all affected individuals while healthy individuals and controls were found genotypically normal. The results were further validated by RFLP analysis as c.1138 G > A substitution generates a unique recognition site for SfcI endonuclease. Following SfcI digestion, the electrophoretic pattern of three bands/DNA fragments for each patient is indicative of heterozygous status of the disease allele. In silico studies of the mutant FGFR3 protein predicted to adversely affect the stability of FGFR3 protein. Mutation in the transmembrane domain may adversely affect the dimerization efficiency and overall stability of the FGFR3, leading to a constitutively active protein. As a result, an uncontrolled intracellular signaling or negative bone growth regulation leads to achondroplasia. Our findings support the fact that p.G380R is a common mutation among diverse population of the world and like other countries, can be used as a molecular diagnosis marker for achondroplasia in Pakistan.

18 May 2016 in International Journal of Ophthalmology
Verified
Journal Article
Open access
SSShamim Saleha
Shamim Saleha
MAMuhammad Ajmal
Muhammad Ajmal
MJMuhammad Jamil
Muhammad Jamil
MNMuhammad Nasir
Muhammad Nasir
AHAbdul Hameed
Abdul Hameed
The identification of c.1304A>C pathogenic mutation in PCDH15 gene and its association with Usher syndrome in a consanguineous Pakistani family is the first example of a missense mutation of PCDH15 causing USH1 phenotype. In previous reports, it was hypothesized that severe mutations such as truncated protein of PCDH15 led to the Usher I phenotype and that missense variants are mainly responsible for non-syndromic hearing impairment.